Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours - a Multi-Site Retrospective Cohort Study as Part of the Global Germ-Cell Cancer Group (G3) Consortium

Condition:   Testicular Neoplasms Intervention:   Other: Review of Health Information Sponsors:   Walter and Eliza Hall Institute of Medical Research;   Royal Marsden NHS Foundation Trust;   Melbourne Health Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials